These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12036205)

  • 1. Possible mechanisms of the fibrate-induced increase in serum creatinine.
    Tsimihodimos V; Miltiadous G; Bairaktari E; Elisaf M
    Clin Nephrol; 2002 May; 57(5):407-8. PubMed ID: 12036205
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective effect of coenzyme Q10 in simvastatin and gemfibrozil induced rhabdomyolysis in rats.
    Farswan M; Rathod SP; Upaganlawar AB; Semwal A
    Indian J Exp Biol; 2005 Oct; 43(10):845-8. PubMed ID: 16235714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy.
    Layne RD; Sehbai AS; Stark LJ
    Ann Pharmacother; 2004 Feb; 38(2):232-4. PubMed ID: 14742756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrate-induced increase in serum urea and creatinine levels.
    Tsimihodimos V; Bairaktari E; Elisaf M
    Nephrol Dial Transplant; 2002 Apr; 17(4):682; author reply 682. PubMed ID: 11917069
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?
    Broeders N; Knoop C; Antoine M; Tielemans C; Abramowicz D
    Nephrol Dial Transplant; 2000 Dec; 15(12):1993-9. PubMed ID: 11096145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrate treatment can increase serum creatinine levels.
    Tsimihodimos V; Kakafika A; Elisaf M
    Nephrol Dial Transplant; 2001 Jun; 16(6):1301. PubMed ID: 11390746
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety considerations with fibrate therapy.
    Davidson MH; Armani A; McKenney JM; Jacobson TA
    Am J Cardiol; 2007 Mar; 99(6A):3C-18C. PubMed ID: 17368275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gemfibrozil induced impotence].
    Alcalá Pedrajas JN; Prada Pardal JL
    An Med Interna; 1998 Mar; 15(3):175-6. PubMed ID: 9567433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
    SantaCruz PL; González A; León ME; Fernández MY
    Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
    [No Abstract]   [Full Text] [Related]  

  • 10. Creatininemia during fibrate therapy: a reply to Lipscombe et al.
    Hottelart C; Achard JM; Fournier A
    Clin Nephrol; 2001 Jul; 56(1):85-6. PubMed ID: 11499666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrate-induced deterioration of renal function].
    Polanco N; Hernández E; González E; Gutiérrez Martínez E; Bello I; Gutiérrez-Millet V; García F; Morales E; Praga M
    Nefrologia; 2009; 29(3):208-13. PubMed ID: 19554053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of lipid disorders.
    Broeders N; Knoop C; Abramowicz D
    N Engl J Med; 1999 Dec; 341(26):2020-1. PubMed ID: 10617402
    [No Abstract]   [Full Text] [Related]  

  • 13. Deterioration in renal function associated with fibrate therapy.
    Goffin E; Devuyst O; Pirson Y
    Clin Nephrol; 2001 Jun; 55(6):490. PubMed ID: 11434364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
    Kind AH; Zakowski LJ; McBride PE
    WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antilipemic therapy and rhabdomyolysis].
    Paragh G; Balogh Z; Romics L
    Orv Hetil; 2003 Mar; 144(11):515-20. PubMed ID: 12731338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate can increase serum creatinine levels in renal insufficiency.
    Paul S; Mohan V
    J Assoc Physicians India; 2006 Apr; 54():337. PubMed ID: 16944623
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.
    Kyrklund C; Backman JT; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Jun; 73(6):538-44. PubMed ID: 12811363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.